Inducing primary brainstem gliomas in genetically engineered mice using RCAS/TVA retroviruses and Cre/loxP recombination

STAR Protoc. 2023 Mar 17;4(1):102094. doi: 10.1016/j.xpro.2023.102094. Epub 2023 Feb 13.

Abstract

Genetically engineered mice are commonly used to model brainstem gliomas in pre-clinical research. One technique for inducing primary tumors in these genetically engineered mice involves delivering viral vectors containing the code for gene-editing proteins. We present a protocol for generating primary brainstem gliomas using the RCAS-TVA retroviral delivery system and the Cre/loxP gene editing system. We describe steps for transfecting and harvesting chicken fibroblast cells, intracranially injecting cells into mice, imaging primary tumors, and treating primary tumors with focal, image-guided brain irradiation. For complete details on the use and execution of this protocol, please refer to Deland et al. (2021).1.

Keywords: Cancer; Health Sciences; Microscopy; Model Organisms; Molecular Biology; Molecular/Chemical Probes; Neuroscience.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Stem Neoplasms* / genetics
  • Brain Stem Neoplasms* / therapy
  • Glioma* / genetics
  • Glioma* / therapy
  • Mice
  • Recombination, Genetic
  • Retroviridae / genetics

Substances

  • Cre recombinase